These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27528029)

  • 1. An oncolytic adenovirus that expresses the HAb18 and interleukin 24 genes exhibits enhanced antitumor activity in hepatocellular carcinoma cells.
    Yuan S; Fang X; Xu Y; Ni A; Liu XY; Chu L
    Oncotarget; 2016 Sep; 7(37):60491-60502. PubMed ID: 27528029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
    Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
    Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
    Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X
    Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin.
    Ma B; Wang Y; Zhou X; Huang P; Zhang R; Liu T; Cui C; Liu X; Wang Y
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):419-29. PubMed ID: 25240826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
    Liu X; Cao X; Wei R; Cai Y; Li H; Gui J; Zhong D; Liu XY; Huang K
    Cancer Gene Ther; 2012 Jan; 19(1):49-57. PubMed ID: 21979578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.
    Zhao L; Gu J; Dong A; Zhang Y; Zhong L; He L; Wang Y; Zhang J; Zhang Z; Huiwang J; Qian Q; Qian C; Liu X
    Hum Gene Ther; 2005 Jul; 16(7):845-58. PubMed ID: 16000066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma.
    Zhang Y; Fang L; Zhang Q; Zheng Q; Tong J; Fu X; Jiang X; Su C; Zheng J
    Mol Oncol; 2013 Jun; 7(3):346-58. PubMed ID: 23182495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma.
    Chen W; Wu Y; Liu W; Wang G; Wang X; Yang Y; Chen W; Tai Y; Lu M; Qian Q; Zhang Q; Chen G
    Cancer Lett; 2011 Aug; 307(1):93-103. PubMed ID: 21504839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant antitumor activity of oncolytic adenovirus expressing human interferon-beta for hepatocellular carcinoma.
    He LF; Gu JF; Tang WH; Fan JK; Wei N; Zou WG; Zhang YH; Zhao LL; Liu XY
    J Gene Med; 2008 Sep; 10(9):983-92. PubMed ID: 18618506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced sensitivity of hepatocellular carcinoma cells to chemotherapy with a Smac-armed oncolytic adenovirus.
    Pan QW; Zhong SY; Liu BS; Liu J; Cai R; Wang YG; Liu XY; Qian C
    Acta Pharmacol Sin; 2007 Dec; 28(12):1996-2004. PubMed ID: 18031615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Anti-tumour Effects of Quercetin and Oncolytic Adenovirus expressing TRAIL in Human Hepatocellular Carcinoma.
    Zou H; Zheng YF; Ge W; Wang SB; Mou XZ
    Sci Rep; 2018 Feb; 8(1):2182. PubMed ID: 29391509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
    Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
    Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
    El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
    J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumor effect of TRAIL and IL-24 with complete eradication of hepatoma in the CTGVT-DG strategy.
    Cai Y; Liu X; Huang W; Zhang K; Liu XY
    Acta Biochim Biophys Sin (Shanghai); 2012 Jun; 44(6):535-43. PubMed ID: 22635106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic adenovirus-mediated MDA-7/IL-24 overexpression enhances antitumor activity in hepatocellular carcinoma cell lines.
    Xiao CW; Xue XB; Zhang H; Gao W; Yu Y; Chen K; Zheng JW; Wang CJ
    Hepatobiliary Pancreat Dis Int; 2010 Dec; 9(6):615-21. PubMed ID: 21134831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis.
    Zheng JN; Pei DS; Sun FH; Liu XY; Mao LJ; Zhang BF; Wen RM; Xu W; Shi Z; Liu JJ; Li W
    Cancer Biol Ther; 2009 Apr; 8(7):599-606. PubMed ID: 19305163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel antibody fragment targeting HAb18G/CD147 with cytotoxicity and decreased immunogenicity.
    Zhu H; Yang B; Yang X; Wang L; Xu J; Liao C; Feng Q; Tang H; Hu L; Chen Z; Li Y
    Cancer Biol Ther; 2009 Jun; 8(11):1035-44. PubMed ID: 19377306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines.
    Xue XB; Xiao CW; Zhang H; Lu AG; Gao W; Zhou ZQ; Guo XL; Zhong MA; Yang Y; Wang CJ
    World J Gastroenterol; 2010 Oct; 16(37):4677-84. PubMed ID: 20872968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.